193 related articles for article (PubMed ID: 25572106)
1. New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90.
Hermane J; Bułyszko I; Eichner S; Sasse F; Collisi W; Poso A; Schax E; Walter JG; Scheper T; Kock K; Herrmann C; Aliuos P; Reuter G; Zeilinger C; Kirschning A
Chembiochem; 2015 Jan; 16(2):302-11. PubMed ID: 25572106
[TBL] [Abstract][Full Text] [Related]
2. New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus.
Wu CZ; Moon AN; Jang JH; Lee D; Kang SY; Park JT; Ahn JS; Hwang BY; Kim YH; Lee HS; Hong YS
J Antibiot (Tokyo); 2011 Jun; 64(6):461-3. PubMed ID: 21448187
[No Abstract] [Full Text] [Related]
3. New geldanamycin derivatives with anti Hsp properties by mutasynthesis.
Hermane J; Eichner S; Mancuso L; Schröder B; Sasse F; Zeilinger C; Kirschning A
Org Biomol Chem; 2019 May; 17(21):5269-5278. PubMed ID: 31089638
[TBL] [Abstract][Full Text] [Related]
4. Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
Onodera H; Kaneko M; Takahashi Y; Uochi Y; Funahashi J; Nakashima T; Soga S; Suzuki M; Ikeda S; Yamashita Y; Rahayu ES; Kanda Y; Ichimura M
Bioorg Med Chem Lett; 2008 Mar; 18(5):1588-91. PubMed ID: 18243703
[TBL] [Abstract][Full Text] [Related]
5. Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition.
Patel K; Piagentini M; Rascher A; Tian ZQ; Buchanan GO; Regentin R; Hu Z; Hutchinson CR; McDaniel R
Chem Biol; 2004 Dec; 11(12):1625-33. PubMed ID: 15610846
[TBL] [Abstract][Full Text] [Related]
6. New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis.
Eichner S; Floss HG; Sasse F; Kirschning A
Chembiochem; 2009 Jul; 10(11):1801-5. PubMed ID: 19554593
[No Abstract] [Full Text] [Related]
7. Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Shi G; Lu C; Shen Y
Chem Biol Drug Des; 2015 Feb; 85(2):181-8. PubMed ID: 24903735
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
9. Potent cytotoxic C-11 modified geldanamycin analogues.
Tian ZQ; Wang Z; MacMillan KS; Zhou Y; Carreras CW; Mueller T; Myles DC; Liu Y
J Med Chem; 2009 May; 52(10):3265-73. PubMed ID: 19405528
[TBL] [Abstract][Full Text] [Related]
10. New geldanamycin analogs from Streptomyces hygroscopicus.
Wu CZ; Jang JH; Ahn JS; Hong YS
J Microbiol Biotechnol; 2012 Nov; 22(11):1478-81. PubMed ID: 23124337
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of macbecin as an Hsp90 inhibitor.
Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ
J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975
[TBL] [Abstract][Full Text] [Related]
13. Bioreduction of aryl azides during mutasynthesis of new ansamitocins.
Mancuso L; Jürjens G; Hermane J; Harmrolfs K; Eichner S; Fohrer J; Collisi W; Sasse F; Kirschning A
Org Lett; 2013 Sep; 15(17):4442-5. PubMed ID: 23981134
[TBL] [Abstract][Full Text] [Related]
14. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067
[TBL] [Abstract][Full Text] [Related]
15. Fluorine- and rhenium-containing geldanamycin derivatives as leads for the development of molecular probes for imaging Hsp90.
Wuest F; Bouvet V; Mai B; LaPointe P
Org Biomol Chem; 2012 Sep; 10(33):6724-31. PubMed ID: 22825378
[TBL] [Abstract][Full Text] [Related]
16. The interplay between mutasynthesis and semisynthesis: generation and evaluation of an ansamitocin library.
Eichner S; Knobloch T; Floss HG; Fohrer J; Harmrolfs K; Hermane J; Schulz A; Sasse F; Spiteller P; Taft F; Kirschning A
Angew Chem Int Ed Engl; 2012 Jan; 51(3):752-7. PubMed ID: 22135226
[No Abstract] [Full Text] [Related]
17. The missing C-17 O-methyltransferase in geldanamycin biosynthesis.
Yin M; Lu T; Zhao LX; Chen Y; Huang SX; Lohman JR; Xu LH; Jiang CL; Shen B
Org Lett; 2011 Jul; 13(14):3726-9. PubMed ID: 21682254
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
Shen G; Wang M; Welch TR; Blagg BS
J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Xu H; Wu Y; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Oct; 85():359-70. PubMed ID: 25105924
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
Le Brazidec JY; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF
J Med Chem; 2004 Jul; 47(15):3865-73. PubMed ID: 15239664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
